Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

425 projects found matching your search criteria :

  1. Development of technology for producing emulsions stabilized using biosurfactants dissolved in the oil phase. Increasing...

    Call: OPUS 27 , Panel: ST8

    Principal investigator: dr hab. Marcel Krzan

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  2. Coating dextran nanocarriers with immune cell membranes as a way to transport active substances across the blood-brain b...

    Call: PRELUDIUM 23 , Panel: ST11

    Principal investigator: Daniel Filip Wyleziński

    Politechnika Warszawska

  3. New functional MOF@hydroxyapatite composites for the treatment of bacterial bone infections

    Call: PRELUDIUM 23 , Panel: ST11

    Principal investigator: Weronika Bodylska-Maj

    Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

  4. Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing t...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Damian Nestor Plażuk

    Uniwersytet Łódzki

  5. Molecular mechanisms underlying the liver injury induced by ulipristal acetate treatment

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Aleksandra Natalia Łupińska

    Instytut Rozrodu Zwierząt i Badań Żywności PAN

  6. Stimuli-Responsive Metal-Organic Frameworks: Structural Dynamics and Sorption Properties

    Call: SONATINA 8 , Panel: ST5

    Principal investigator: dr Marzena Pander

    Uniwersytet Jagielloński

  7. Manufacture of a new generation three-dimensional "drug-on-chip" materials with controlled release of active agents dedi...

    Call: SONATINA 8 , Panel: ST8

    Principal investigator: dr Wiktoria Dominika Tomal

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  8. Stimuli-responsive anion transporters for targeted drug delivery

    Call: OPUS 26 , Panel: ST5

    Principal investigator: dr hab. Michał Jan Chmielewski

    Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

  9. Semaglutide and neurodevelopment: investigating risks arising from prenatal exposure to a widely popular drug for diabet...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Wnuk

    Instytut Farmakologii PAN

  10. Taming aggregation with AmyloGraph 2.0: a database and prediction models of amyloid self-assembly modulators

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Michał Jan Burdukiewicz

    Uniwersytet Medyczny w Białymstoku

  11. Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  12. Synthesis, characterization, and evaluation of the biological activity of innovative thermosensitive suppositories compr...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Ewa Olędzka

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  13. New biomimetic 3D materials for potential use in advanced therapies of bone tissue diseases - 3D BioBone

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Joanna Krystyna Kolmas

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  14. Organometallic (Fe, Ru, Ir, Os) phospho-inducers of drug-resistant cancer cells' ferroptosis

    Call: OPUS 26 , Panel: ST4

    Principal investigator: dr hab. Urszula Katarzyna Komarnicka

    Uniwersytet Wrocławski, Wydział Chemii

  15. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  16. Mucoadhesive nanospheres as an intravesical form of monomethyl auristatin E

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Jelonek

    Centrum Materiałów Polimerowych i Węglowych PAN

  17. Integrated multi-omics approach to accelerate anticancer drug discovery by targeting metabolic reprogramming in human co...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Danuta Dudzik

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  18. Bacterial membrane carriers targeting tumor-associated microbes for advanced cancer therapy

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Monika Kluzek

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  19. Application of superparamagnetic iron oxide nanoparticles (SPION) in inhaled theranostic systems containing antifungal d...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Gabriela Małgorzata Wyszogrodzka-Gaweł

    Uniwersytet Jagielloński, Collegium Medicum

  20. Design and characterisation of sealing materials of prosthetic obturator being additionally a cytostatic drug reservoir....

    Call: OPUS 26 , Panel: ST8

    Principal investigator: prof. Anna Trusek

    Politechnika Wrocławska

  21. Evaluating the antibacterial activity of the bacteriophage protein targeting Staphylococcus aureus, including drug-resis...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Zuzanna Maria Kaźmierczak

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  22. Controlled release of active pharmaceutical ingredients (API) based on Carrier-Ion-API interactions

    Call: SONATA 19 , Panel: ST5

    Principal investigator: dr Mariusz Piotr Sandomierski

    Politechnika Poznańska, Wydział Technologii Chemicznej

  23. Unlocking the potential of ion-transfer voltammetry based electronic tongues for date-rape drug detection in real sample...

    Call: SONATA BIS 13 , Panel: ST4

    Principal investigator: dr Emilia Katarzyna Witkowska-Nery

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  24. Design and Development of Serine Hydroxymethyltransferase-2 (SHMT2) Inhibitors Blocking Tumor Growth

    Call: SONATA BIS 13 , Panel: NZ7

    Principal investigator: dr hab. Miłosz Ruszkowski

    Instytut Chemii Bioorganicznej PAN

  25. Carbon quantum dots in the synthesis of functional polymeric materials using photoinduced atom transfer radical polymeri...

    Call: PRELUDIUM BIS 5 , Panel: ST5

    Principal investigator: prof. Paweł Artur Chmielarz

    Politechnika Rzeszowska im. Ignacego Łukasiewicza, Wydział Chemiczny

  26. Click chemistry in microfluidic channels for the construction of nanomaterials against drug-resistant microbes.

    Call: PRELUDIUM BIS 5 , Panel: ST11

    Principal investigator: dr hab. Marek Brzeziński

    Centrum Badań Molekularnych i Makromolekularnych PAN

  27. Directed screening and evaluation of novel bactericidal compounds active againsttubercle bacilli and Mycobacterium absce...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Jarosław Dziadek

    Instytut Biologii Medycznej PAN

  28. Extracellular vesicles of probiotic yeast as carriers of biologically active molecules transferred to human intestinal c...

    Call: OPUS 25 , Panel: NZ9

    Principal investigator: dr hab. Jolanta Mierzejewska

    Politechnika Warszawska, Wydział Chemiczny

  29. Curdlan-based biomaterial as a nanostructure carrier for controlled and targeted drug delivery in the treatment of deep ...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: dr Aleksandra Nurzyńska

    Uniwersytet Medyczny w Lublinie

  30. Development of bioresorbable polymer materials for the personalized ureteralstents releasing the antispasmodic drug

    Call: OPUS 25 , Panel: ST11

    Principal investigator: prof. Janusz Edward Kasperczyk

    Centrum Materiałów Polimerowych i Węglowych PAN

  31. Cuproptosis, a novel pathway of regulated cell death as a therapeutic target in treatment-naïve and targeted therapy-res...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: dr hab. Mariusz Łukasz Hartman

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  32. Electromagnetic field-supported systems for transdermal drug delivery.

    Call: OPUS 25 , Panel: ST8

    Principal investigator: prof. Rafał Mariusz Rakoczy

    Zachodniopomorski Uniwersytet Technologiczny w Szczecinie, Wydział Technologii i Inżynierii Chemicznej

  33. Multifunctional emulsion-based transporters for personalised cancer treatment

    Call: OPUS 25 , Panel: ST8

    Principal investigator: prof. Ewa Dłuska

    Politechnika Warszawska, Wydział Inżynierii Chemicznej i Procesowej

  34. Search for novel IKK-β inhibitors in the context of diseases with neuroinflammatory origin – structure-based drug design...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Emilia Aleksandra Sługocka

    Uniwersytet Jagielloński, Collegium Medicum

  35. INVADOPODIA IN AXL-DRIVEN CANCER INVASION AND DRUG RESISTANCE

    Call: OPUS 25 , Panel: NZ3

    Principal investigator: dr Daria Paulina Zdżalik-Bielecka

    Uniwersytet Warszawski, Wydział Biologii

  36. "I like to move it, move it" – molecular dynamics-driven optimization of ligand residence time as an opportunity to impr...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: dr hab. Sabina Marta Podlewska

    Instytut Farmakologii PAN

  37. Chiral hybrids of quinones and quinols with double anticancer and antimicrobial activity against drug-resistant pathogen...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Ryszard Józef Ostaszewski

    Instytut Chemii Organicznej Polska Akademia Nauk

  38. Bis(benzosiloxaboroles) as a new class of potential antibiotics - a perspective solution to growing problem of antimicro...

    Call: PRELUDIUM 22 , Panel: ST5

    Principal investigator: Krzysztof Nowicki

    Politechnika Warszawska, Wydział Chemiczny

  39. Computational alchemy and experimental validation: a hybrid approach for designing new antimicrobial peptides

    Call: PRELUDIUM 22 , Panel: NZ1

    Principal investigator: Piotr Maciej Chyży

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  40. Designing Active Inhibitors of SARS-CoV-2 Methyltransferases

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Alex Jun Matsuda

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

  41. Decrypting the "sulfation code" of glycosaminoglycans for understanding their function in the extracellular matrix

    Call: OPUS 25 , Panel: ST4

    Principal investigator: dr hab. Sergey Samsonov

    Uniwersytet Gdański, Wydział Chemii

  42. Conjugates of peptide nucleic acids with aminoglycosides and fluoroquinolones as a novel strategy to target multi-drug r...

    Call: PRELUDIUM 22 , Panel: ST5

    Principal investigator: Izabela Siekierska

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  43. Modeling of the excipients effect on drug skin permeability

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Laura Agnieszka Krumpholz

    Uniwersytet Jagielloński, Collegium Medicum

  44. Chemosensors with molecularly imprinted polymers for determination of antiviral active drug substances in body fluids - ...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: dr Krzysztof Robert Noworyta

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  45. Design, Synthesis and Characterization of Functionalized 1,2,4-Trioxanes/Trioxepanes for Antimalarial and Anticancer Use

    Call: SONATINA 7 , Panel: NZ7

    Principal investigator: dr Mohit Kumar Tiwari

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  46. Targeting nucleic acid-protein complexes with small molecules using a deep-learning framework

    Call: SONATINA 7 , Panel: NZ1

    Principal investigator: dr Ryhor Nikalayeu

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  47. Senolytic nanoplatform to target and eliminate skin cancer Zombie cells

    Call: M-ERA.NET 2022 , Panel: ST5

    Principal investigator: dr hab. Anna Karolina Lewińska

    Uniwersytet Rzeszowski, Kolegium Nauk Przyrodniczych

  48. Targeted inhibition of hypusination pathway

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: dr Przemysław Marek Grudnik

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

  49. Targeted poloxamer micelles with selected drugs as a strategy for overcoming the mechanisms of multidrug resistance in p...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  50. Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr Urszula Helena Piotrowska

    Warszawski Uniwersytet Medyczny

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy